KL rs9536686: What Your Genotype Means
The rs9536686 variant is a missense single nucleotide polymorphism in the human KL gene, often designated alongside rs9536314 (F352V) as a core defining marker of the functional KL-VS haplotype. Carrying one copy of this haplotype has been correlated in research cohorts with elevated circulating klotho protein, enhanced cognitive measures, and altered longevity patterns. However, population findings show mixed effects, and the observed advantages appear restricted specifically to heterozygous individuals.
What each genotype means
Typical Klotho expression
This genotype represents the most common form of the KL gene in many populations. Research indicates that individuals without the KL-VS haplotype may have different baseline levels of circulating Klotho protein compared to those who carry the variant.
This is the most common genotype, found in the vast majority of individuals across most global populations.
Enhanced cognitive and longevity association
Carrying one copy of the KL-VS haplotype (often represented by the T allele at this position) has been associated in several studies with higher circulating Klotho levels, larger cortical brain volume, and better performance on tests of executive function. While some research links this heterozygosity to increased longevity, findings across different populations have been mixed and are not definitive.
The KL-VS haplotype is carried by approximately 10% to 15% of individuals of European ancestry, with lower frequencies observed in African and East Asian populations.
Reduced survival association
Some early research suggested that individuals homozygous for the KL-VS haplotype may experience a decrease in survival compared to non-carriers or heterozygotes. It is important to note that these associations are complex, and other studies have found no significant difference in longevity outcomes for this specific genotype.
This genotype is relatively rare, occurring in a small percentage of the population even within groups where the KL-VS haplotype is more common.
Genetic Architecture: rs9536686 and the KL-VS Haplotype
The single nucleotide polymorphism rs9536686 resides on chromosome 13q13.1 within the human KL gene. It encodes a missense substitution that is tightly linked to another notable coding change, C370S (rs9527025), together forming what geneticists term the KL-VS haplotype. In genetic literature, rs9536686 is frequently tracked in tandem with rs9536314, representing the F352V (phenylalanine to valine at codon 352) alteration. Because these single nucleotide polymorphisms exist in near-complete linkage disequilibrium across European populations, the presence of the minor G allele at this site reliably tags the functional KL-VS allele. Missense changes in this region alter the catalytic and structural domains of the resulting protein, modifying both its secretion efficiency into systemic circulation and its stability. Rather than causing a monogenic condition or classical mendelian disorder, rs9536686 acts as a common complex trait modifier that alters physiological baseline functioning across several organ systems.
Biological Role of the Klotho Protein
The KL gene encodes klotho, an anti-aging transmembrane protein named after the Greek mythological fate who spins the thread of life. Klotho functions in two primary forms: a full-length, single-pass transmembrane protein that acts as an obligate co-receptor for fibroblast growth factor 23 (FGF23) to regulate systemic phosphate and vitamin D metabolism, and a shed, circulating humoral factor. The cleaved extracellular domain enters the bloodstream and cerebrospinal fluid, where it acts broadly to modulate insulin and insulin-like growth factor signaling, suppress oxidative stress, regulate ion channels, and support neurovascular integrity. In the central nervous system, klotho is heavily concentrated in the choroid plexus and hippocampus, where it supports synaptic plasticity, long-term potentiation, and the retention of NMDA receptor subunits such as GluN2B. Functional studies indicate that the amino acid substitutions in the KL-VS haplotype alter the proteolytic release and enzymatic activity of the protein, changing circulating klotho concentrations in carrier individuals.
Longevity and Cognitive Research: A Non-Linear Phenotype
Epidemiological interest in rs9536686 began when researchers identified an enrichment of heterozygous carriers among human centenarians and elderly cohorts. Subsequent neurocognitive studies demonstrated that heterozygous KL-VS carriers exhibited better executive functioning, larger gray matter volume in regions like the dorsolateral prefrontal cortex, and resilience against certain age-related cognitive declines. Strikingly, this association follows an inverted-U, non-linear pattern: the putative health and longevity advantages are observed only in heterozygous individuals carrying one copy of the variant allele. Individuals homozygous for the KL-VS haplotype (carrying two minor alleles) do not experience these benefits and have demonstrated shorter lifespans and elevated cardiovascular markers in several cohorts. Furthermore, larger prospective cohorts, such as the Heinz Nixdorf Recall Study and certain Danish population analyses, have failed to replicate cognitive benefits or observed neutral to slightly lower performance, underscoring that evidence strength remains moderate, heterogeneous, and context-dependent.
Population Frequency and Ancestral Distribution
The distribution of rs9536686 varies widely across global ancestries, demonstrating pronounced ancestral stratification. In populations of European descent, the minor allele frequency typically ranges between 10% and 15%, translating to roughly 20% to 26% of individuals carrying a single copy (heterozygotes) and around 1% to 1.5% carrying two copies (homozygotes). By contrast, the variant is substantially rarer in African and East Asian populations, where minor allele frequencies often register below 2% to 5%. Because the vast majority of historical longevity and cognitive cohort studies focusing on the KL-VS haplotype were conducted in European-descended cohorts, the generalizability of these findings to other ancestral groups remains uncertain. Allele tracking across large-scale genomic databases like gnomAD highlights that frequencies must be interpreted within an ancestry-specific context when assessing potential statistical contributions to complex traits.
Clinical Realities: What This Information Means for You
Understanding your rs9536686 genotype provides insight into population-level statistical traits, but it does not represent a diagnostic test or an immutable medical forecast. Carrying the KL-VS haplotype does not guarantee longevity or superior cognitive health, nor does its absence imply premature cognitive decline. Complex human outcomes like cognitive resilience, cardiovascular health, and lifespan are overwhelmingly polygenic, shaped by thousands of interacting genetic loci alongside potent lifestyle and environmental exposures. Modifiable factors, including cardiovascular fitness, dietary quality, cognitive engagement, blood pressure control, and restorative sleep, exert substantially greater clinical effects on long-term brain health than any single genetic variant. rs9536686 should be viewed purely through an educational lens as an intriguing genetic modifier rather than a determinant of personal health outcomes.
How common is this variant?
The minor allele frequency for rs9536686 ranges between 10% and 15% in populations of European ancestry, resulting in approximately 20% to 25% heterozygote prevalence. In contrast, the variant occurs at much lower frequencies in African, East Asian, and other non-European populations.
Frequently asked questions
What is the relationship between rs9536686 and the KL-VS haplotype?
The rs9536686 variant resides in the KL gene and is in high linkage disequilibrium with rs9536314 (F352V) and rs9527025 (C370S). Together, these tightly linked missense single nucleotide polymorphisms define the functional KL-VS haplotype frequently evaluated in human longevity research.
Does having the favorable genotype guarantee a longer life?
No. While carrying a single copy of the KL-VS haplotype is statistically associated with modest cognitive and survival advantages in some cohort studies, human lifespan is a complex polygenic trait influenced by thousands of genes and major environmental factors.
Why is having two copies of the KL-VS variant considered higher-attention?
The biological advantages linked to the KL-VS variant exhibit a non-linear, heterozygous-only effect. Individuals carrying two copies (homozygotes) do not exhibit improved cognitive performance and have shown elevated cardiovascular risks and reduced survival relative to heterozygotes in several longitudinal studies.
Can medical treatments or supplements increase klotho levels?
Currently, there are no approved therapies or regulated dietary supplements proven to increase klotho protein levels in humans safely. However, standard healthy lifestyle practices—such as regular aerobic exercise, management of blood pressure, and renal care—consistently support endogenous klotho expression and general brain health.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9536686?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KL
This variant in the Klotho gene is associated with variations in chronic hemodialysis mortality and susceptibility to urinary calculi.
A non-synonymous variant (p.Cys370Ser) that, as part of the KL-VS haplotype, is associated with longevity, cognitive resilience, and altered Klotho protein secretion, though findings regarding its direct impact on lifespan remain inconsistent across large cohorts.